Oncodesign Precision Medicine
UnverifiedConducts research and development work on new therapeutic and diagnostic tools.
Launch date
Employees
Market cap
€99.7m
Net debt
(€2.6m)
Enterprise valuation
$113m (Public information from Dec 2022)
Share price
€14.42 AlONC.PA
Company register number 892226762
Dijon Bourgogne-Franche-Comté (HQ)